1. Home
  2. TRUP vs OGN Comparison

TRUP vs OGN Comparison

Compare TRUP & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • OGN
  • Stock Information
  • Founded
  • TRUP 2000
  • OGN 1923
  • Country
  • TRUP United States
  • OGN United States
  • Employees
  • TRUP N/A
  • OGN N/A
  • Industry
  • TRUP Medical Specialities
  • OGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUP Health Care
  • OGN Health Care
  • Exchange
  • TRUP Nasdaq
  • OGN Nasdaq
  • Market Cap
  • TRUP 2.1B
  • OGN 2.5B
  • IPO Year
  • TRUP 2014
  • OGN N/A
  • Fundamental
  • Price
  • TRUP $55.15
  • OGN $9.68
  • Analyst Decision
  • TRUP Buy
  • OGN Hold
  • Analyst Count
  • TRUP 6
  • OGN 4
  • Target Price
  • TRUP $51.80
  • OGN $18.00
  • AVG Volume (30 Days)
  • TRUP 514.5K
  • OGN 3.8M
  • Earning Date
  • TRUP 08-07-2025
  • OGN 08-05-2025
  • Dividend Yield
  • TRUP N/A
  • OGN 0.83%
  • EPS Growth
  • TRUP N/A
  • OGN N/A
  • EPS
  • TRUP N/A
  • OGN 2.88
  • Revenue
  • TRUP $1,321,538,000.00
  • OGN $6,294,000,000.00
  • Revenue This Year
  • TRUP $11.30
  • OGN N/A
  • Revenue Next Year
  • TRUP $6.01
  • OGN $1.11
  • P/E Ratio
  • TRUP N/A
  • OGN $3.36
  • Revenue Growth
  • TRUP 14.08
  • OGN N/A
  • 52 Week Low
  • TRUP $26.96
  • OGN $8.01
  • 52 Week High
  • TRUP $57.90
  • OGN $23.10
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 71.93
  • OGN 53.19
  • Support Level
  • TRUP $54.58
  • OGN $9.73
  • Resistance Level
  • TRUP $57.34
  • OGN $10.30
  • Average True Range (ATR)
  • TRUP 1.94
  • OGN 0.35
  • MACD
  • TRUP 0.20
  • OGN 0.06
  • Stochastic Oscillator
  • TRUP 86.50
  • OGN 64.98

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: